Rocklatan: payments to doctors
Payments that named Rocklatan as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $9.7M
- Providers
- 16,768
- Transactions
- 82,210
- Average per transaction
- $118
The per-transaction average — $118 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 16,768 providers the average total is $580, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aerie Pharmaceuticals, Inc. | $6,562,918 | 67.5% |
| Alcon | $3,012,468 | 31.0% |
| Alcon Research LLC | $153,223 | 1.6% |